The Efficacy and Safety of Glibenclamide in Improving Cerebral Edema and Neurological Outcomes in Stroke: a GRADE-Evaluated Systematic Review and Meta-analysis with Subgroup Analysis.

Neurocrit Care · 2025 · PMC12647293 · PMID 40629214

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

Safety analysis did not report any significant rise in serious adverse event risk, hypoglycemia, or decompressive craniectomy risk, although a numerical trend for more hypoglycemia was observed in the glibenclamide group.

also in 1,012 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.